story-banner

How 1mg is changing under Tata Digital

author-image

Supriya Roy

41 reads
author-image

Madhav Chanchani

121 reads
author-image

Supriya Roy

41 reads
author-image

Madhav Chanchani

121 reads

In a crowded market comprising conglomerates, MNCs and cash-rich startups, 1mg has spent the last year improving its supply chain and expanding. The Tata Digital-owned company is now raising more capital, but will it be enough to take on the heavily funded Pharmeasy and Reliance-backed Netmeds?

July 27, 2022

11 MINS READ

About two years ago, just when the first wave of the Covid-19 pandemic sparked a spike in demand for deliveries by online pharmacy players, 1mg Technologies hit the market to raise a new round of funding. 

When it started out, 1mg was not meant to be an online pharma company. At least, that was not founder Prashant Tandon’s and then co-founder Sameer Maheshwari’s original business idea back in 2011. The startup was an offshoot of e-commerce platform Healthkart, best known for selling supplements. It was known as Healthkartplus – an online marketplace for health devices, personal care, fitness and nutrition supplements, sports nutrition, eye-care and so on, having tie-ups with top distributors and retailers in different cities. 

But in 2015, Tandon, a McKinsey consultant with an MBA from Stanford, decided to demerge the business. 

For subscribers only

Premium Reads

>>

View More >>

Deeply reported and objective news on the country´s fastest-growing companies and the people behind them.